Literature DB >> 31857748

Utility of Preoperative Imaging for Predicting Pelvic Lateral Lymph Node Metastasis in Lower Rectal Cancer.

Koji Numata1,2, Yusuke Katayama1, Sho Sawazaki1, Akio Higuchi1, Soichiro Morinaga1, Yasushi Rino3, Munetaka Masuda3, Manabu Shiozawa1.   

Abstract

This study aimed to investigate the diagnostic power of preoperative imaging for lateral pelvic lymph node (LPLN) metastasis. A total of 79 patients with advanced lower rectal cancer were preoperatively examined with pelvic enhanced computed tomography and underwent primary resection and LPLN dissection (LPLD) from 2007 to 2014 in our institute. The maximum LPLN was selected to be measured in both the long- and short-axis diameters by picture archiving and communication system (PACS) and was compared with the histopathological results. Receiver operating characteristic (ROC) curves were used to identify the optimal cut-off scores, and we evaluated the accuracy of the thresholds. Twenty-one patients (26.6%) had LPLN metastasis. In the ROC analysis, the criterion of 7.6 mm or larger in the long-axis diameter was used as the optimal threshold for metastasis (area under the curve (AUC) = 0.938) and the criteria of 5.5 mm or larger in the short axis (AUC = 0.946). On the basis of these cut-off scores, the criteria in the long axis represented 95.2% sensitivity, 91.5% specificity, 83.3% positive predictive value (PPV), 98.2% negative predictive value (NPV), and 93.7% accuracy. In contrast, there was 95.2% sensitivity, 89.7% specificity, 76.9% PPV, 98.1% NPV, and 91.1% accuracy in the short axis. Preoperative PACS imaging was considered an optimal tool for diagnosing LPLN metastasis in patients with advanced lower rectal cancer. It is suggested to become the index for considering LPLD adaptation. © Indian Association of Surgical Oncology 2019.

Entities:  

Keywords:  Computed tomography; Lateral pelvic lymph node; Rectal cancer

Year:  2019        PMID: 31857748      PMCID: PMC6895291          DOI: 10.1007/s13193-019-00947-0

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  21 in total

1.  Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.

Authors:  Shin Fujita; Takayuki Akasu; Junki Mizusawa; Norio Saito; Yusuke Kinugasa; Yukihide Kanemitsu; Masayuki Ohue; Shoichi Fujii; Manabu Shiozawa; Takashi Yamaguchi; Yoshihiro Moriya
Journal:  Lancet Oncol       Date:  2012-05-15       Impact factor: 41.316

2.  Importance of extended lymphadenectomy with lateral node dissection for advanced lower rectal cancer.

Authors:  Y Moriya; K Sugihara; T Akasu; S Fujita
Journal:  World J Surg       Date:  1997-09       Impact factor: 3.352

3.  Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer.

Authors:  M Ueno; M Oya; K Azekura; T Yamaguchi; T Muto
Journal:  Br J Surg       Date:  2005-06       Impact factor: 6.939

4.  Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study.

Authors: 
Journal:  BMJ       Date:  2006-09-19

5.  Preoperative evaluation of pelvic lateral lymph node of patients with lower rectal cancer: comparison study of MR imaging and CT in 53 patients.

Authors:  Kazuo Arii; Katsunari Takifuji; Shozo Yokoyama; Kenji Matsuda; Takashi Higashiguchi; Toshiji Tominaga; Yoshimasa Oku; Masaji Tani; Hiroki Yamaue
Journal:  Langenbecks Arch Surg       Date:  2006-07-18       Impact factor: 3.445

6.  Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison.

Authors:  Gina Brown; Catherine J Richards; Michael W Bourne; Robert G Newcombe; Andrew G Radcliffe; Nicholas S Dallimore; Geraint T Williams
Journal:  Radiology       Date:  2003-05       Impact factor: 11.105

7.  Accuracy of high-resolution magnetic resonance imaging in preoperative staging of rectal cancer.

Authors:  Takayuki Akasu; Gen Iinuma; Masashi Takawa; Seiichiro Yamamoto; Yukio Muramatsu; Noriyuki Moriyama
Journal:  Ann Surg Oncol       Date:  2009-07-18       Impact factor: 5.344

8.  Investigation of the freely available easy-to-use software 'EZR' for medical statistics.

Authors:  Y Kanda
Journal:  Bone Marrow Transplant       Date:  2012-12-03       Impact factor: 5.483

9.  Lateral pelvic lymph node dissection can be omitted in lower rectal cancer in which the longest lateral pelvic and perirectal lymph node is less than 5 mm on MRI.

Authors:  Shimpei Ogawa; Michio Itabashi; Tomoichiro Hirosawa; Takuzo Hashimoto; Yoshiko Bamba; Shingo Kameoka
Journal:  J Surg Oncol       Date:  2013-10-25       Impact factor: 3.454

10.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer.

Authors:  Toshiaki Watanabe; Michio Itabashi; Yasuhiro Shimada; Shinji Tanaka; Yoshinori Ito; Yoichi Ajioka; Tetsuya Hamaguchi; Ichinosuke Hyodo; Masahiro Igarashi; Hideyuki Ishida; Soichiro Ishihara; Megumi Ishiguro; Yukihide Kanemitsu; Norihiro Kokudo; Kei Muro; Atsushi Ochiai; Masahiko Oguchi; Yasuo Ohkura; Yutaka Saito; Yoshiharu Sakai; Hideki Ueno; Takayuki Yoshino; Narikazu Boku; Takahiro Fujimori; Nobuo Koinuma; Takayuki Morita; Genichi Nishimura; Yuh Sakata; Keiichi Takahashi; Osamu Tsuruta; Toshiharu Yamaguchi; Masahiro Yoshida; Naohiko Yamaguchi; Kenjiro Kotake; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2015-03-18       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.